Systematic Review of the Neural Effect of Electroconvulsive Therapy in Patients with Schizophrenia: Hippocampus and Insula as the Key Regions of Modulation
Sun-Young Moon, Minah Kim, Silvia Kyungjin Lho, Sanghoon Oh, Se Hyun Kim, Jun Soo Kwon
Psychiatry Investig. 2021;18(6):486-499.   Published online 2021 Jun 24     DOI: https://doi.org/10.30773/pi.2020.0438
A eficácia da terapia eletroconvulsiva no tratamento da Esquizofrenia
Marisa Bezerra De Araújo, Guilherme Nobre Nogueira , Rafaela Fernandes Gonçalves
Cuadernos de Educación y Desarrollo.2024;[Epub]     CrossRef
Effects of electroconvulsive therapy on functional brain networks in patients with schizophrenia
Yibo Geng, Hongxing Zhang, Zhao Dong, Haisan Zhang
BMC Psychiatry.2024;[Epub]     CrossRef
Eletroconvulsoterapia em quadros de esquizofrenia
Gabriel Luiz de Jesus Ribeiro , Murilo Cintra Husni
Cuadernos de Educación y Desarrollo.2024;[Epub]     CrossRef
Are neurodevelopmental structural pathologies of the insula potential biomarkers for schizophrenia risk?
Susanna Gebhardt, Henry A. Nasrallah
Biomarkers in Neuropsychiatry.2024; 10: 100086.     CrossRef
Sex differences in factors influencing hospital-acquired pneumonia in schizophrenia patients receiving modified electroconvulsive therapy
Mi Yang, Yan Yang, Liju Liu, Di Kong, Min Xu, Xincheng Huang, Cheng Luo, Guocheng Zhao, Xiangyang Zhang, Yan Huang, Yunzhong Tu, Zezhi Li
Frontiers in Psychiatry.2023;[Epub]     CrossRef
Resting-state functional MRI in treatment-resistant schizophrenia
Noora Tuovinen, Alex Hofer
Frontiers in Neuroimaging.2023;[Epub]     CrossRef
Commonalities and differences in ECT-induced gray matter volume change between depression and schizophrenia
Hirotsugu Kawashima, Shimpei Yamasaki, Manabu Kubota, Masaaki Hazama, Yasutaka Fushimi, Jun Miyata, Toshiya Murai, Taro Suwa
NeuroImage: Clinical.2023; 38: 103429.     CrossRef
Electroconvulsive therapy and seizure: a double-edged sword?
Hye-Rim Shin, Minah Kim, Kyung-Il Park
encephalitis.2023; 3(4): 103.     CrossRef
Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment
Xiaoe Lang, Dongmei Wang, Dachun Chen, Meihong Xiu, Huixia Zhou, Li Wang, Bo Cao, Xiangyang Zhang
Neurotherapeutics.2022; 19(1): 399.     CrossRef
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, Sakiko Tsugawa, Kazunari Yoshida, Hideaki Tani, Yoji Hirano, Shinsuke Koike, Daiki Sasabayashi, Haruyuki Katayama, Eric Plitman, Kazutaka Ohi, Fumihiko Ueno, Fernando Caravaggio, Teruki Koizumi, Philip Gerretse
Molecular Psychiatry.2022; 27(7): 2950.     CrossRef
Driving brain state transitions in major depressive disorder through external stimulation
Shengpei Wang, Hongwei Wen, Shuang Qiu, Peng Xie, Jiang Qiu, Huiguang He
Human Brain Mapping.2022; 43(17): 5326.     CrossRef